These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34020325)

  • 1. Pulmonary embolism in patients with multiple sclerosis treated with teriflunomide: A series of three cases.
    Krajnc N; Brecl Jakob G; Gomezelj S; Šega Jazbec S
    Clin Neurol Neurosurg; 2021 Jul; 206():106685. PubMed ID: 34020325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teriflunomide, a potential novel cause of chronic active colitis.
    Kővári B; Zachs J; Murchie B; Lauwers GY
    Histopathology; 2020 Dec; 77(6):1000-1001. PubMed ID: 32323888
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity associated with the use of teriflunomide in a patient with multiple sclerosis: A case report.
    Ferreira CM; Vasconcelos-Pereira EF; Oliveira VM; Salgado PR; Domingos JA; Monreal MTFD; Guerra-Shinohara EM; Gubert VT
    Medicine (Baltimore); 2021 Dec; 100(51):e28246. PubMed ID: 34941096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells.
    Tilly G; Cadoux M; Garcia A; Morille J; Wiertlewski S; Pecqueur C; Brouard S; Laplaud D; Degauque N
    Front Immunol; 2021; 12():730342. PubMed ID: 34721394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriflunomide-associated urolithiasis: a new adverse reaction explained by its uricosuric effect.
    Largeau B; Béra F; Vannier J; Jonville-Béra AP
    Fundam Clin Pharmacol; 2021 Oct; 35(5):930-932. PubMed ID: 33458875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriflunomide: Pediatric First Approval.
    Paik J
    Paediatr Drugs; 2021 Nov; 23(6):609-613. PubMed ID: 34595696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ▼Teriflunomide for multiple sclerosis.
    Drug Ther Bull; 2014 Jul; 52(7):81-4. PubMed ID: 25012149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience.
    Vukusic S; Coyle PK; Jurgensen S; Truffinet P; Benamor M; Afsar S; Purvis A; Poole EM; Chambers C
    Mult Scler; 2020 Jun; 26(7):829-836. PubMed ID: 30968734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebound syndrome in two cases of MS patients after teriflunomide cessation.
    Labauge P; Ayrignac X; Prin P; Charif M; Carra-Dalliere C
    Acta Neurol Belg; 2022 Oct; 122(5):1381-1384. PubMed ID: 35802339
    [No Abstract]   [Full Text] [Related]  

  • 11. Teriflunomide-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Khurana D; Kaur G; Sendhil Kumaran M; Choudhary R; Ashraf R; Thakur V
    Clin Exp Dermatol; 2021 Jan; 46(1):166-169. PubMed ID: 32557734
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?
    Pourcher V; Yeung J; Le Pimpec-Barthes F; Maillart E; Gibault L; Boussouar S
    Rev Neurol (Paris); 2022 Mar; 178(3):266-267. PubMed ID: 34579947
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients.
    Gil-Bernal R; González-Caballero JL; Espinosa-Rosso R; Gómez-Gómez C
    Sci Rep; 2021 Jun; 11(1):12533. PubMed ID: 34131191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmar pustular psoriasis associated with teriflunomide treatment.
    Negrotto L; Correale J
    Mult Scler Relat Disord; 2019 Jan; 27():400-402. PubMed ID: 30513502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.
    Jones RR; Turkoz I; Ait-Tihyaty M; DiBernardo A; Houtchens MK; Havrdová EK
    J Womens Health (Larchmt); 2024 Apr; 33(4):480-490. PubMed ID: 38301149
    [No Abstract]   [Full Text] [Related]  

  • 16. Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.
    Bucello S; Annovazzi P; Ragonese P; Altieri M; Barcella V; Bergamaschi R; Bianchi A; Borriello G; Buscarinu MC; Callari G; Capobianco M; Capone F; Cavalla P; Cavarretta R; Cortese A; De Luca G; Di Filippo M; Dattola V; Fantozzi R; Ferraro E; Filippi MM; Gasperini C; Grimaldi LME; Landi D; Re ML; Mallucci G; Manganotti P; Marfia GA; Mirabella M; Perini P; Pisa M; Realmuto S; Russo M; Tomassini V; Torri-Clerici VLA; Zaffaroni M; Zuliani C; Zywicki S; Filippi M; Prosperini L
    J Neurol; 2021 Aug; 268(8):2922-2932. PubMed ID: 33616742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis.
    Son M; McEwan L; Ubaidat M; Bovell K; Morrow SA
    Mult Scler; 2020 Nov; 26(13):1801-1803. PubMed ID: 32031458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.
    Papadopoulou A; Kappos L; Sprenger T
    Expert Opin Drug Saf; 2015 May; 14(5):749-59. PubMed ID: 25687236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosis.
    Landais A; Alhendi R; Gouverneur A; Teron-Aboud B
    Mult Scler Relat Disord; 2017 Oct; 17():92-94. PubMed ID: 29055483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.
    Chitnis T; Banwell B; Kappos L; Arnold DL; Gücüyener K; Deiva K; Saubadu S; Hu W; Benamor M; Le-Halpere A; Truffinet P; Tardieu M
    Mult Scler; 2024 Jun; 30(7):833-842. PubMed ID: 38619037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.